Trade-Ideas LLC identified

PRA Health



TST Recommends

) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified PRA Health as such a stock due to the following factors:

  • PRAH has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $12.7 million.
  • PRAH has traded 80,407 shares today.
  • PRAH is trading at 8.58 times the normal volume for the stock at this time of day.
  • PRAH is trading at a new high 4.17% above yesterday's close.

'Strong on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as M&A events, material stock news, analyst upgrades, insider buying, buying from 'superinvestors,' or that hedge funds and momentum traders are piling into a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize. In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in PRAH with the Ticky from Trade-Ideas. See the FREE profile for PRAH NOW at Trade-Ideas

More details on PRAH:

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development services to the biotechnology and pharmaceutical industries worldwide. PRAH has a PE ratio of 58. Currently there are 6 analysts that rate PRA Health a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for PRA Health has been 481,700 shares per day over the past 30 days. PRA Health has a market cap of $2.6 billion and is part of the health care sector and health services industry. Shares are down 3.1% year-to-date as of the close of trading on Thursday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.


TheStreet Quant Ratings

rates PRA Health as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, weak operating cash flow and poor profit margins.

Highlights from the ratings report include:

  • Despite its growing revenue, the company underperformed as compared with the industry average of 12.0%. Since the same quarter one year prior, revenues rose by 10.7%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • PRA HEALTH SCIENCES INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, PRA HEALTH SCIENCES INC turned its bottom line around by earning $1.29 versus -$0.37 in the prior year. This year, the market expects an improvement in earnings ($2.45 versus $1.29).
  • Net operating cash flow has decreased to $2.70 million or 20.61% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Life Sciences Tools & Services industry. The net income has significantly decreased by 192.9% when compared to the same quarter one year ago, falling from $17.19 million to -$15.97 million.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.